Long-Term Antibiotic Management for COPD

Patient Selection Criteria

The European Respiratory Society recommends reserving long-term antibiotics for patients with post-bronchodilator FEV₁/FVC <0.70 and FEV₁ % predicted <80% 3
The American Thoracic Society suggests considering long-term antibiotics for patients with more than three acute exacerbations requiring steroid therapy per year, with at least one requiring hospital admission in the previous year 1, 2
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends considering long-term antibiotics for patients with persistent exacerbations despite optimized non-pharmacological and pharmacological therapies 1, 2

The British Thoracic Society recommends azithromycin 250 mg three times weekly as the preferred regimen, with moderate quality evidence showing reduction in exacerbation rates 1, 2, 3
The European Respiratory Society suggests an alternative regimen of azithromycin 500 mg three times weekly, which may be reduced to 250 mg if gastrointestinal side effects occur while maintaining benefit 2

The American College of Chest Physicians recommends a minimum trial period of 6 months and an optimal duration of up to 12 months to assess impact on exacerbation rate 1, 2
The European Respiratory Society suggests considering drug holidays to reduce resistance development 2

The American Heart Association recommends carefully evaluating cardiovascular risk factors, particularly for ventricular arrhythmias, before prescribing macrolides 3
The European Respiratory Society warns that macrolides can cause QTc prolongation and cardiac arrhythmias, and recommends ECG monitoring before and during treatment 1, 2

The Cochrane Review shows that macrolides reduce exacerbations by 33% compared to placebo, with a modest improvement in quality of life, but no significant reduction in hospitalizations 1
The European Respiratory Society notes that there is no mortality benefit demonstrated in 12-month studies, and no impact on disease progression, spirometry, or exercise capacity 1, 3